Resource Allocation

  • Read more: International Aid, Public Health, and Corruption

    International Aid, Public Health, and Corruption

    By I. Glenn Cohen My wonderful HLS colleague Matthew Stephenson has just launched the Global Anticorruption Blog (GAB). As it happens, his first two posts may be of interest to BOH readers, especially those  may be of interest to readers interested in international aid for public health projects, of the sort supported by the Gates…

  • Read more: Kevin Outterson on the Search for New Antibiotics

    Kevin Outterson on the Search for New Antibiotics

    Kevin Outterson appeared on NPR’s “Here & Now” to discuss the growing problem of antibiotic resistance and possible ways to incentivize development of new antibiotics. From the interview: On the misuse of antibiotics “We should think of this as a global resource that needs to be conserved and taken care of. So antibiotics should never be…

  • Read more: Prioritizing Parks and Patients

    Prioritizing Parks and Patients

    By Nathaniel Counts During the government shutdown in October 2013, a battle in part over the future of healthcare reform, a non-negligible amount of media attention focused on the shutdown of public parks.  Perhaps because the parks were the least expected casualty of the shutdown, or the most ludicrous – many are, after all, large…

  • Read more: Capturing Value in Advanced Medical Imaging

    Capturing Value in Advanced Medical Imaging

    By Michael S. Young On December 12, a bipartisan bill entitled the Excellence in Diagnostic Imaging Utilization Act of 2013 (HR 3705) was introduced in the House of Representatives which would require clinicians to use electronic clinical decision support tools (CDS) before ordering advanced diagnostic imaging tests for Medicare patients.  Structured around appropriate use criteria  developed by…

  • Read more: Only a Right to Health

    Only a Right to Health

    By Nathaniel Counts Human rights disaggregates otherwise related issues into separate rights.  We discuss rights to health, education, housing, association, etc., and, in countries where these rights are codified, we litigate each one separately in the courts.  We also know that each of these issues for which there is a corresponding right is, to some…

  • Read more: Medical Advice and the Limits of Therapeutic Influence

    Medical Advice and the Limits of Therapeutic Influence

    By Michael Young It is estimated that 500,000 patients are discharged from U.S. hospitals against the recommendations of medical staff each year.  This category of discharges, dubbed discharges against medical advice (DAMA), encompasses cases in which patients request to be discharged in spite of countervailing medical counsel to remain hospitalized.  Despite safeguards that exist to ensure that…

  • Read more: PAPER NOW AVAILABLE for 11/18 Health Law Workshop w/Aaron Kesselheim

    PAPER NOW AVAILABLE for 11/18 Health Law Workshop w/Aaron Kesselheim

    By The Petrie-Flom Center Aaron Kesselheim is a physician and an Assistant Professor of Medicine at the Harvard Medical School. He will be speaking at the Petrie-Flom Health Law Workshop on Monday, November 18, at 5:00pm, on “Do March-In Rights Protect Public Interests in Medical Products Arising from Federally-Funded Research?” For more details on the workshop, including information…

  • Read more: HHIP: Evaluating Effective Charities – GiveWell cofounder Elie Hassenfeld: Tuesday, 8 PM

    HHIP: Evaluating Effective Charities – GiveWell cofounder Elie Hassenfeld: Tuesday, 8 PM

    Harvard High Impact Philanthropy presents: Evaluating Effective Charities with Elie Hassenfeld of GiveWell How can you maximize the impact of your charitable giving?  What distinguishes the most effective causes and organizations? Elie Hassenfeld, co-founder and co-Executive Director of GiveWell, will describe how his organization is revolutionizing charity evaluation with completely transparent, rigorous analysis. Q&A to follow. 8 pm, Tuesday, Nov. 12; Sever 102…

  • Read more: 11/21: Neil Flanzraich on “Responsibility and Integrity in the Pharmaceutical Industry”

    11/21: Neil Flanzraich on “Responsibility and Integrity in the Pharmaceutical Industry”

    By The Petrie-Flom Center Please join the Petrie-Flom Center for a lecture by Neil Flanzraich on responsible pricing strategy, access to care, clinical trial design, outsourcing, and other topics that raise thorny but crucial issues for pharmaceutical and biotechnology companies.  There will be substantial time for Q&A. Mr. Flanzraich graduated from HLS in 1968, and was appointed…

  • Read more: EMTALA and Patient Hoarding

    EMTALA and Patient Hoarding

    By Jeremy Kreisberg It is clear that EMTALA aims to prevent hospitals from dumping patients that require emergency care until these patients are stabilized.  But whether EMTALA also prevents hospitals from hoarding emergency patients to their detriment is far less clear.  Recently, the Tenth Circuit confronted this question in Genova v. Banner Health, a case…